Select for export Attitudes toward psychedelics and psychedelic-assisted psychotherapy among Australian mental healthcare providers Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/00048674251346679 PubMed 40660894 Copy citation Copy BibTeX Australian & New Zealand Journal of Psychiatry 2025-07-14 Zohaib Nadeem, Stephen Parker, Hugh McGovern, Bianca Sebben, Lena Oestreich OpenAlex Published psilocybin DepressionPTSDChronic Pain Observational Study More
Select for export Psychedelics for Alcohol Use Disorder: A Narrative Review with Candidate Mechanisms of Action. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s40263-025-01199-z PubMed 40640527 Copy citation Copy BibTeX Unknown journal 2025-07-09 Miller EA, Capone C, Eaton E, Swift RM, Haass-Koffler CL. Europe PMC Published psilocybin AddictionNeuroplasticityMechanism of Action Clinical Trial More
Select for export Treatment with LSD and psilocybin at the department of psychiatry at Frederiksberg Hospital in Denmark from 1960 to 1973: an analysis of 324 cases Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/08039488.2025.2529449 PubMed 40635579 Copy citation Copy BibTeX Nordic Journal of Psychiatry 2025-07-09 Jens Larsen, Pernille Kølbæk, Søren Dinesen Østergaard OpenAlex Published psilocybin SpiritualityReview ArticleAdverse Events Review Article More
Select for export The Medial PrefrontalCortex Modulates Psychedelic-likeEffects of Psilocin Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1021/acsptsci.5c00324.s001 Copy citation Copy BibTeX Figshare 2025-07-07 Miyuan Zhang (21677016), Haojiang Zhai (21677019), Longwei Yang (21677022), Haohong Li (5164970), Xiaohui Wang (19899) OpenAlex Published psilocybinpsilocin DepressionNeuroplasticityMechanism of Action Animal Study More
Select for export Psilocybin treatment extends cellular lifespan and improves survival of aged mice Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41514-025-00244-x PubMed 40628762 Copy citation Copy BibTeX npj Aging 2025-07-07 Kosuke Kato, Jennifer Kleinhenz, Yoon-Joo Shin, Cristian Coarfa, Ali John Zarrabi, Louise Hecker OpenAlex Published psilocybinpsilocin PharmacologyMechanism of ActionReceptor Pharmacology Animal Study More
Select for export The Medial Prefrontal Cortex Modulates Psychedelic-like Effects of Psilocin Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1021/acsptsci.5c00324 PubMed 40810162 Copy citation Copy BibTeX ACS Pharmacology & Translational Science 2025-07-07 Miyuan Zhang, Haiyan Zhai, Longwei Yang, Haohong Li, Xiaohui Wang OpenAlex Published psilocybinpsilocin DepressionMechanism of ActionReceptor Pharmacology Animal Study More
Select for export Unraveling the policies, legislations, and regulations of psychedelics in Australia, Canada, Netherlands, New Zealand, and India. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.healthpol.2025.105392 PubMed 40694950 Copy citation Copy BibTeX Unknown journal 2025-07-07 Joga R, Yerram S, Patnam JD, Choudhary KK, Varpe P, Raghuvanshi RS Europe PMC Published psilocybin DepressionPTSDClinical Trial Clinical Trial More
Select for export An open-label, dose-escalation trial of psilocybin-assisted therapy for bipolar 2 depression Abstract available at the source but not redistributed here. Read at source. Details DOI 10.31234/osf.io/97cqx_v1 Copy citation Copy BibTeX PsyArXiv 2025-07-06 Szigeti B. PsyArXiv PREPRINT (not peer reviewed) psilocybin DepressionAnxietyHeadache / Migraine Other More
Select for export An open-label, dose-escalation trial of psilocybin-assisted therapy for bipolar 2 depression Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX PsyArXiv 2025-07-06 Authors unavailable PsyArXiv PREPRINT (not peer reviewed) psilocybin DepressionAnxietyHeadache / Migraine Other More
Select for export Explore the effect of psilocybin on depression and anxiety Abstract available at the source but not redistributed here. Read at source. Details DOI 10.61173/rcg8me57 Copy citation Copy BibTeX Arts Culture and Language 2025-07-05 Yutong Song OpenAlex Published psilocybin DepressionAnxietyAddiction Other More
Select for export Accurate and Interpretable Prediction of Antidepressant Treatment Response from Receptor-informed Neuroimaging Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2025.07.02.662710 Copy citation Copy BibTeX bioRxiv 2025-07-02 Tolle HM, Luppi AI, Lawn T, Roseman L, Nutt D, Carhart-Harris RL bioRxiv PREPRINT (not peer reviewed) psilocybin DepressionBrain ImagingMechanism of Action Clinical Trial More
Select for export Psychedelic and Medicinal Mushrooms: Potent Source of Active Metabolites and Medicines Abstract available at the source but not redistributed here. Read at source. Details DOI 10.2174/0115734072383313250602052217 Copy citation Copy BibTeX Current Bioactive Compounds 2025-07-01 Priya Chaudhary, Pracheta Janmeda OpenAlex Published psilocybin PharmacologyOxidative StressReview Article Review Article More
Select for export Single-dose (10 mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder: A pharmacological challenge study Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.comppsych.2025.152619 PubMed 40618640 Copy citation Copy BibTeX Comprehensive Psychiatry 2025-07-01 Luca Pellegrini, Naomi Fineberg, Sorcha O'Connor, Ana Maria Frota Lisbôa Pereira de Souza, Kate Godfrey, Sara Reed OpenAlex Published psilocybin DepressionOCDChronic Pain Clinical Trial More
Select for export Psilocybin Use in an Intercollegiate Athlete with Persisting Symptoms After Concussion: A Case Report Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3390/psychoactives4030022 Copy citation Copy BibTeX Psychoactives 2025-06-30 David W. Lawrence, Alex P. Di Battista, Michael G. Hutchison OpenAlex Published psilocybin Headache / MigraineReceptor PharmacologyAging Case Report More
Select for export Exploring serotonergic psychedelics as a treatment for personality disorders. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.neuropharm.2025.110413 PubMed 40081794 Copy citation Copy BibTeX Neuropharmacology 2025-06-30 Carrithers BM, Roberts DE, Weiss BM, King JD, Carhart-Harris RL, Gordon AR PubMed Published psilocybin PharmacologyMechanism of ActionPersonality Change Review Article More
Select for export Exploring the Therapeutic Effects of Psychedelics Administered to Military Veterans in Naturalistic Retreat Settings Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/brb3.70660 PubMed 40619953 Copy citation Copy BibTeX Brain and Behavior 2025-06-30 Megan Calnan, Grace Blest-Hopley, Chris Busch, Milly Adams, Simon Ruffell, Theodore Piper OpenAlex Published psilocybin DepressionAnxietyPTSD Other More
Select for export What fMRI studies say about the nature of the psychedelic effect: a scoping review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fnins.2025.1606798 PubMed 40666257 Copy citation Copy BibTeX Unknown journal 2025-06-30 Beneš M, Páleníček T, Horáček J. Europe PMC Published psilocybin Brain ImagingMechanism of ActionDefault Mode Network Review Article More
Select for export Psychedelic drugs for the treatment of substance use disorders. No abstract availability was recorded for this entry. Details DOI 10.1080/17512433.2025.2541103 PubMed 40726066 Copy citation Copy BibTeX Expert review of clinical pharmacology 2025-06-30 Sofuoglu M, De Aquino JP, MacLean RR PubMed Published psilocybin Addiction Other More
Select for export Chemical Composition and Biological Activities of Psilocybe Mushrooms: Gaps and Perspectives. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3390/ph18070989 PubMed 40732278 Copy citation Copy BibTeX Unknown journal 2025-06-30 Luz MA, Guedes HVS, Bisneto ABM, Jesus RA, Galdino TP, Oliveira LC Europe PMC Published psilocybinpsilocin Review ArticleObservational Study Review Article More
Select for export Control Group Outcomes in Trials of Psilocybin, SSRIs, or Esketamine for Depression: A Meta-Analysis. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1001/jamanetworkopen.2025.24119 PubMed 40736734 Copy citation Copy BibTeX Unknown journal 2025-06-30 Hieronymus F, López E, Werin Sjögren H, Lundberg J. Europe PMC Published psilocybin DepressionReceptor PharmacologyClinical Trial Randomized Controlled Trial More
